Tag: Heart Failure
AHA: Sacubitril/Valsartan No More Beneficial for Chronic Advanced CHF
No benefit seen versus valsartan for reducing NT-proBNP levels for patients with chronic advanced heart failure and reduced ejection fraction
Cases of Takotsubo Syndrome Up in Middle-Aged, Older Women
Majority of cases (88.3 percent) seen in women, especially those aged 50 years or older; incidence higher in middle-aged men than younger men
SGLT2 Inhibitors May Cut Risk for Heart Failure Hospitalization
SGLT2 inhibitors, compared with GLP-1 RAs, linked to lower risk for heart failure hospitalization in patients with T2DM, with or without CVD
Early Rhythm Control Key in A-Fib and Heart Failure
Reduction seen in composite primary outcomes of CV death, stroke, hospitalization for worsening of heart failure or ACS
~40 Percent of Incident Heart Failure Diagnoses Occur in Acute Care
46 percent of those diagnosed in acute care had potential heart failure symptoms in previous six months
Methamphetamine-Linked Heart Failure Up in California
Increase of 585 percent seen in methamphetamine-associated cardiomyopathy/heart failure hospitalizations from 2008 to 2018
Heart Failure Linked to Increased Incidence of Cancer
Increased rates of cancer seen among women and men and for cancer at multiple sites, including lip, oral cavity, pharynx, respiratory organs
Statin Use May Cut Cancer Risk in Heart Failure Patients
Reduced risk for incident cancer and cancer-related mortality in patients with heart failure appears to depend on duration of statin use
Sotagliflozin Ups Days Alive, Out of Hospital in T2DM, Heart Failure
Increase in rate of days alive and out of hospital mainly due to drop in rate of days dead for patients with T2DM, worsening heart failure
ACC: Tailored Rehab Beneficial for Heart Failure in Seniors
Greater physical improvement seen with early, transitional, tailored, progressive rehab intervention including physical function domains
